> Quick view: from 1 January 2027, the HPV9 vaccine (Gardasil 9) joins Singapore's national immunisation schedules and Subsidised Vaccine List. It covers HPV types behind about 90% of cervical cancers, against about 70% for HPV2. Eligible Singaporean girls get it fully subsidised at CHAS GP clinics and polyclinics, eligible Singaporean women get means-tested subsidies of up to 75%, PRs get subsidies at polyclinics, and MediSave can be used. Sec 1 and 2 girls switch to HPV9 in school. Nothing changes before January.
The Ministry of Health, the Communicable Diseases Agency and the Health Promotion Board announced the change in a joint statement on 2 October 2026. It matters most to two groups: parents of girls aged 9 to 14, and women aged 15 to 26 who have not yet been vaccinated.
What is changing
From 1 January 2027, HPV9 is added to three lists at once: the National Childhood Immunisation Schedule (NCIS), the National Adult Immunisation Schedule (NAIS) and the Subsidised Vaccine List (SVL). Being on the SVL is what makes it cheaper at CHAS GP clinics and polyclinics.
HPV vaccination is recommended for females aged 9 to 26. HPV2 (Cervarix) stays on both schedules as an alternative, so this widens the choice rather than replacing one vaccine with another outside schools.
| HPV2 (Cervarix) | HPV9 (Gardasil 9) | |
|---|---|---|
| HPV types 16 and 18 (about 70% of cervical cancers) | Yes | Yes |
| Additional types (a further 20% or so) | No | Yes |
| Total cervical cancer coverage | About 70% | About 90% |
| On national schedules | Yes, and stays | From 1 January 2027 |
HPV4 (the original Gardasil) is no longer available in Singapore and has been removed from both schedules.
How much is subsidised
These are the settings and subsidy levels in MOH's statement, all from 1 January 2027:
| Who | Where | Subsidy |
|---|---|---|
| Eligible Singaporean children | CHAS GP clinics and polyclinics | Full subsidy |
| Eligible Singaporean adults | CHAS GP clinics and polyclinics | Means-tested, up to 75% |
| Eligible Permanent Residents | Polyclinics only | Subsidised |
| Sec 1 and 2 female students | In school, HPB programme | No charge |
MediSave can also be used for HPV9 by people in the recommended groups under the NCIS and NAIS, up to the MediSave Chronic and Preventive Care limit of $700 a year, or $1,000 for patients being treated for two or more Chronic Disease Management Programme conditions, or one with recognised complications.
MOH has not published the dollar co-payment per dose for HPV9 in this statement. It points readers to its updated Subsidised Vaccine List page for details, so check that page or your clinic for the exact charge.
The dosing rules, updated
The Expert Committee on Immunisation updated its recommendations at the same time:
- First dose at age 9 to 14: two doses, with either HPV2 or HPV9.
- First dose at age 15 to 26: three doses.
- Started but not finished by 26: the remaining doses can be completed after 26, as early as possible, up to age 45.
- Started on HPV2 or HPV4 with doses still to go: you may finish the series with HPV9. The committee says mixed schedules like this are safe and protect against the strains covered by both vaccines.
- Already completed with HPV2, HPV4 or HPV9: no additional HPV9 doses are recommended.
That last point has a cost attached. MOH says subsidies and MediSave do not apply to extra HPV9 doses for people who have already completed the recommended doses. If you are fully vaccinated and want HPV9 anyway, expect to pay the full private price.
What happens in schools
HPB's school-based programme already vaccinates Secondary 1 and 2 girls free of charge. From 1 January 2027, HPV9 replaces HPV2 for students who have yet to start or finish their series.
If your daughter is in Secondary 1 this year and got HPV2 as her first dose, she will be scheduled to receive HPV9 as her second dose in school in 2027. Girls who have already completed the series are not eligible for more doses under the school programme.
Who does not benefit
- People already fully vaccinated. No extra dose is recommended, and none is subsidised.
- Anyone wanting HPV9 at the subsidised rate before 1 January 2027. The subsidy and MediSave use only start on that date.
- PRs at GP clinics. The statement mentions PR subsidies at polyclinics only.
- Women over 26 who never started. The recommended range is 9 to 26; only a series begun by 26 can be finished up to 45. Talk to your doctor if you are outside the range.
How to book
From 1 January 2027, book at a participating CHAS GP clinic through vaccine.gov.sg, or make an appointment at a polyclinic. Healthier SG enrollees are encouraged to book at their enrolled clinic.
Fine print
- Every figure here comes from the joint MOH, CDA and HPB press release "HPV9 Vaccine Added to National Immunisation Schedules From January 2027" (2 October 2026).
- "Eligible" and "means-tested" follow MOH's own criteria. Confirm your subsidy tier and the per-dose charge with your clinic or MOH before you go.
- This is a summary of an official announcement, not medical or financial advice. Whether and when to vaccinate, and with which vaccine, is a question for your doctor.
Related
- Flu Cases Are Rising and the 2026-27 Vaccine Is Late
- Best Health Screening Packages in Singapore 2026
- Best Pediatrician Clinics in Singapore (2026)
- FairPrice Doubles Its CHAS Discount to 6%
- Pioneer Generation MediSave Top-Up 2026
Cover graphic: MissLobang. Figures: MOH, CDA and HPB.
